This inventor holds 212 USPTO granted patents and 62 published patent applications, plus 24 CIPO patents and 43 EPO patents, primarily in Biotechnology Innovations (CPC class A61B5-14532). Top assignees: Scripps Research Institute, University of California, Medtronic Minimed, Inc.. Active years: 1992-2026.
Inventors with similar research interests:
Location History:
- Oakland, CA (US) (1992 - 2006)
- Barto, PA (US) (2006)
- Saint Thomas, VI (US) (2018)
- La Jolla, CA (US) (2003 - 2024)
- Chatsworth, CA (US) (2013 - 2024)
Company Filing History:
141 out of 1,203 
40 out of 15,964 
21 out of 1,262 
Years Active: 1992-2026
Areas of Expertise:
Title: Peter Schultz: A Leading Innovator in La Jolla, CA
Introduction:
Peter Schultz is a distinguished inventor and researcher based in La Jolla, California. With an impressive portfolio of 168 patents, his contributions to the field of scientific innovation have garnered widespread acclaim. In this article, we will delve into some of his latest patents, highlight his distinguished career, explore his notable collaborations, and recognize his significant contributions to the world of inventions and patents.
Latest Patents:
Among Peter Schultz's recent patents, two noteworthy discoveries stand out:
1. Antimalarial compositions and uses thereof: This patent encompasses the development of compounds, compositions, and methods for treating or preventing malaria. Peter Schultz's research in this area has the potential to make a substantial impact on combating this deadly disease.
2. Composition and methods for inhibiting mammalian sterile 20-like kinase 1: Schultz's scientific contributions in this field revolve around the development of compounds, compositions, and methods for treating diabetes. This innovative approach could prove invaluable in advancing diabetes management and treatment.
Career Highlights:
Peter Schultz has established himself as a respected figure within the scientific community through his diverse professional endeavors. Some of his career highlights include:
- Work at The Scripps Research Institute: Schultz has made significant contributions during his tenure at The Scripps Research Institute, a renowned biomedical research organization. His work here has focused on pushing the boundaries of scientific discovery.
- Involvement with the University of California: Schultz's association with the University of California has further solidified his reputation as a leading innovator. Leveraging the university's resources and research facilities, he has been able to drive forward groundbreaking scientific projects.
Collaborations:
Throughout his career, Peter Schultz has actively collaborated with esteemed colleagues to explore new frontiers of scientific innovation. Two notable collaborators are Zhiwen Zhang and Lei Wang. These partnerships have allowed for the exchange of ideas, knowledge, and expertise, resulting in groundbreaking inventions and patents.
Conclusion:
Peter Schultz's outstanding contributions to innovation and patent development have left an indelible mark on scientific research. His extensive patent portfolio, which includes cutting-edge discoveries related to antimalarial compositions and treatments for diabetes, reflects his commitment to improving human health worldwide. Through his collaborations and affiliations with prestigious research institutions such as The Scripps Research Institute and the University of California, Schultz has created a legacy that will inspire future generations of inventors and innovators.